HemaSphere (Aug 2023)

P666: 1 YEAR RESULTS OF DASATINIB 70MG/DAY VERSUS 100MG/DAY IN NEWLY DIAGNOSED PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE(CML-CP):A PROSPECTIVE RANDOMIZED CONTROLLED STUDY.

  • Dan Yu,
  • Hui Cheng,
  • Jingming Guo,
  • Rui Jiang,
  • Youshan Zhang,
  • Chucheng Wan,
  • Jun Qin,
  • Guolin Yuan,
  • Shiming Chen,
  • Zhuangzhi Yang,
  • Junbin Hu,
  • Yicheng Zhang,
  • Weiming LI

DOI
https://doi.org/10.1097/01.HS9.0000969568.85601.05
Journal volume & issue
Vol. 7
p. e8560105

Abstract

Read online

No abstracts available.